Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ann-Kathrin Stoppek"'
Autor:
Ann-Kathrin Stoppek, Sied Kebir, Andreas Junker, Kathy Keyvani, Stefan Zülow, Lazaros Lazaridis, Teresa Schmidt, Daniela Pierscianek, Martin Stuschke, Ulrich Sure, Christoph Kleinschnitz, Björn Scheffler, Lisa Zimmer, Martin Glas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-4 (2019)
Abstract Background Leptomeningeal metastasis (LM) is a predominantly late stage, devastating complication of a variety of malignant solid tumors. Diagnosis relies predominantly on neurological, radiographic, and cerebrospinal fluid (CSF) assessments
Externí odkaz:
https://doaj.org/article/ca01be0693834cb09b9d301077a5a5b9
Autor:
Sied Kebir, Patrick M. Colletti, Gerald Antoch, Tobias Blau, Kathy Keyvani, Björn Scheffler, Domenico Rubello, Ann-Kathrin Stoppek, Martin Stuschke, Christoph Mönninghoff, Christoph Kleinschnitz, Lale Umutlu, Ulrich Sure, Martin Glas, Cornelius Deuschl, Michael Forsting, Daniela Pierscianek, Ken Herrmann, Manuel Weber, Teresa Schmidt, Lazaros Lazaridis
Publikováno v:
Clinical nuclear medicine. 44(6)
AIMS Amino acid PET and magnetic resonance spectroscopy (MRS) are at the forefront of noninvasive imaging techniques used for detection and subtyping of glioma-suspicious lesions. In this pilot study, we compare L-methyl-C-methionine PET and MRS for
Autor:
Teresa Schmidt, Christoph Kleinschnitz, Daniela Pierscianek, Lazaros Lazaridis, Kathy Keyvani, Björn Scheffler, Ulrich Sure, Martin Glas, Alexander Radbruch, Laurèl Rauschenbach, Martin Stuschke, Ann-Kathrin Stoppek, Michael Forsting, Sied Kebir
Antiangiogenic treatment approaches have failed to improve outcome in randomized trials of high-grade astrocytoma. One key mechanism of resistance to antiangiogenic treatment may concern the upregulation of alternative pro-angiogenic pathways. Regora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb534b8a76881625a9663f09ddec29d1
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85062634465
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85062634465
Publikováno v:
Cancer Research. 79:CT187-CT187
Objective: We aimed to identify and compare glioblastoma (GBM) Phase III trials of the years 2005 to 2018. Methods:A systematic literature search using PubMed and ClinicalTrials.gov was conducted to provide an overview of clinically relevant GBM Phas
Autor:
Ulrich Sure, Martin Glas, Sied Kebir, Daniela Pierscianek, Kathy Keyvani, Ken Herrmann, Teresa Schmidt, Manuel Weber, Cornelius Deuschl, Christoph Moenninghoff, Christoph Kleinschnitz, Lazaros Lazaridis, Ann-Kathrin Stoppek, Björn Scheffler, Judith Boehm
BACKGROUND: Amino acid positron emission tomography (PET) and magnetic resonance spectroscopy (MRS) are at the forefront of non-invasive imaging techniques used for detection and subtyping of glioma-suspicious lesions. No reported studies so far atte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6651a121b8063cf6d63c8543c04247
Publikováno v:
Neuro Oncol
BACKGROUND Tumor Treating Fields (TTFields) are established as modality in glioblastoma (GBM) therapy. GBM is the most aggressive brain tumor in adults, constituting approximately 15 % of all primary brain tumors. At diagnosis, a considerable subgrou
Autor:
Christoph Kleinschnitz, Teresa Schmidt, Ann-Kathrin Stoppek, Daniela Pierscianek, Björn Scheffler, Ulrich Herrlinger, Ulrich Sure, Martin Glas, Lazaros Lazaridis, Sied Kebir, Johannes Weller, Martin Stuschke, Theophilos-Dimitrios Tzaridis, Niklas Schäfer
Publikováno v:
Neuro Oncol
BACKGROUND TTFields combined with TMZ demonstrated significantly improved PFS, OS and long-term survival in newly diagnosed glioblastoma (ndGBM) patients, compared to TMZ monotherapy in the EF-14 trial; independent of MGMT-promotor methylation-status
Autor:
Kebir, Sied, Lazaridis, Lazaros, Weber, Manuel, Deuschl, Cornelius, Stoppek, Ann-Kathrin, Schmidt, Teresa, Mönninghoff, Christoph, Blau, Tobias, Keyvani, Kathy, Umutlu, Lale, Pierscianek, Daniela, Forsting, Michael, Stuschke, Martin, Antoch, Gerald, Sure, Ulrich, Kleinschnitz, Christoph, Scheffler, Björn, Colletti, Patrick M., Rubello, Domenico, Herrmann, Ken
Publikováno v:
Clinical Nuclear Medicine; Jun2019, Vol. 44 Issue 6, pe375-e381, 7p
Autor:
Kebir, Sied, Rauschenbach, Laurel, Radbruch, Alexander, Lazaridis, Lazaros, Schmidt, Teresa, Stoppek, Ann-Kathrin, Pierscianek, Daniela, Stuschke, Martin, Forsting, Michael, Sure, Ulrich, Keyvani, Kathy, Kleinschnitz, Christoph, Scheffler, Björn, Glas, Martin
Publikováno v:
Journal of Cancer Research & Clinical Oncology; Apr2019, Vol. 145 Issue 4, p1037-1042, 6p
Autor:
Stoppek, Ann-Kathrin1,2,3,4 (AUTHOR) Ann-Kathrin.Stoppek@uk-essen.de, Kebir, Sied1,2,3,4,5 (AUTHOR) Sied.Kebir@uk-essen.de, Junker, Andreas6 (AUTHOR) Andreas.Junker@uk-essen.de, Keyvani, Kathy6 (AUTHOR) Kathy.Keyvani@uk-essen.de, Zülow, Stefan7 (AUTHOR) Stefan.Zuelow@uk-essen.de, Lazaridis, Lazaros1,2,3,4 (AUTHOR) Lazaros.Lazaridis@uk-essen.de, Schmidt, Teresa1,2,3,4 (AUTHOR) Teresa.Schmidt@uk-essen.de, Pierscianek, Daniela2,3,8 (AUTHOR) Daniela.Pierscianek@uk-essen.de, Stuschke, Martin9 (AUTHOR) Martin.Stuschke@uk-essen.de, Sure, Ulrich2,3,8 (AUTHOR) Ulrich.Sure@uk-essen.de, Kleinschnitz, Christoph4 (AUTHOR) Christoph.Kleinschnitz@uk-essen.de, Scheffler, Björn5 (AUTHOR) b.scheffler@dkfz-heidelberg.de, Zimmer, Lisa2,3,10 (AUTHOR) Lisa.Zimmer@uk-essen.de, Glas, Martin1,2,3,4,5 (AUTHOR) Martin.Glas@uk-essen.de
Publikováno v:
BMC Cancer. 10/23/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 1 Graph.